Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ODC1 | P11926 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA3 | P07451 | 2/20 | 0.31 |
| ▸ | CA4 | P22748 | 2/20 | 0.31 |
| ▸ | CA6 | P23280 | 2/20 | 0.31 |
| ▸ | CA5A | P35218 | 2/20 | 0.31 |
| ▸ | CA7 | P43166 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.31 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16353341 | 0.96 | MEN1 (0.36) | ODC1NFKB1HTTMEN1THRB | |
| SCHEMBL3998325 | 0.96 | CA1 (0.38) | ODC1NFKB1HTTMEN1THRB | |
| SCHEMBL18902842 | 0.96 | CA1 (0.38) | ODC1NFKB1HTTMEN1THRB | |
| SCHEMBL3996449 | 0.96 | CA1 (0.38) | ODC1NFKB1HTTMEN1THRB | |
| SCHEMBL24870864 | 0.93 | HTT (0.40) | ODC1HTTMEN1THRBKMT2A | |
| SCHEMBL10796626 | 0.93 | ODC1 (0.47) | ODC1NFKB1CA12CA1CA2 | |
| SCHEMBL6826021 | 0.93 | — | — | |
| SCHEMBL3292227 | 0.92 | ODC1 (0.37) | ODC1NFKB1CA12CA1CA2 | |
| SCHEMBL12918856 | 0.92 | ODC1 (0.37) | ODC1NFKB1CA12CA1CA2 | |
| SCHEMBL23193800 | 0.90 | DNM1 (0.50) | ODC1NFKB1MEN1KMT2ACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0375355-B1 | Process for the catalytic reforming of alkylene amines to linearly-extended polyalkylene polyamines | DOW CHEMICAL CO (US) | 1994-02-02 | — | — | EP | claimed |
| US-12091491-B2 | Silylamine compound and latent curing agent comprising said silylamine compound | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2024-09-17 | — | — | US | disclosed |
| US-20220119583-A1 | SILYLAMINE COMPOUND AND LATENT CURING AGENT COMPRISING SAID SILYLAMINE COMPOUND | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2022-04-21 | — | — | US | disclosed |
| EP-3875461-A1 | SILYLAMINE COMPOUND AND LATENT CURING AGENT COMPRISING SAID SILYLAMINE COMPOUND | Koei Chemical Company, Limited (JP) | 2021-09-08 | — | — | EP | disclosed |
| CN-112930352-A | Silylamine compound and latent curing agent containing the same | 广荣化学株式会社 | 2021-06-08 | — | — | CN | disclosed |
| US-10190009-B2 | Ink composition, ink jet recording method using same, and colored material | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2019-01-29 | — | — | US | disclosed |
| US-9587129-B2 | Ink composition and ink set | SEIKO EPSON CORPORATION (JP) | 2017-03-07 | — | — | US | disclosed |
| US-20160160065-A1 | INK COMPOSITION, INK JET RECORDING METHOD USING SAME, AND COLORED MATERIAL | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2016-06-09 | — | — | US | disclosed |
| US-20160137859-A1 | INK COMPOSITION AND INK SET | SEIKO EPSON CORPORATION (JP) | 2016-05-19 | — | — | US | disclosed |
| EP-3015516-A1 | INK COMPOSITION, INK JET RECORDING METHOD USING SAME, AND COLORED MATERIAL | Nippon Kayaku Kabushiki Kaisha (JP) | 2016-05-04 | — | — | EP | disclosed |
| US-5288909-A | Group 5B catalyst, such as niobic acid | THE DOW CHEMICAL COMPANY (US) | 1994-02-22 | — | — | US | disclosed |
| WO-1994003835-A1 | THERMALLY DEVELOPABLE PHOTOSENSITIVE MATERIAL | POLAROID CORPORATION (US) | 1994-02-17 | — | — | WO | disclosed |
| EP-0375355-B1 | Process for the catalytic reforming of alkylene amines to linearly-extended polyalkylene polyamines | DOW CHEMICAL CO (US) | 1994-02-02 | — | — | EP | disclosed |
| US-5256786-A | Catalytic reforming of cyclic alkyleneamines | THE DOW CHEMICAL COMPANY (US) | 1993-10-26 | — | — | US | disclosed |
| WO-1993018017-A1 | CATALYTIC REFORMING OF CYCLIC ALKYLENEAMINES | THE DOW CHEMICAL COMPANY (US) | 1993-09-16 | — | — | WO | disclosed |
| US-5210307-A | Thorium silicate catalyst | THE DOW CHEMICAL COMPANY (US) | 1993-05-11 | — | — | US | disclosed |
| US-5166442-A | Group IIA metal silicates as catalysts | THE DOW CHEMICAL COMPANY (US) | 1992-11-24 | — | — | US | disclosed |
| US-5118850-A | Catalytic reforming of alkyleneamines to linearly-extended polyalkylenepolyamines | THE DOW CHEMICAL COMPANY (US) | 1992-06-02 | — | — | US | disclosed |
| US-4996363-A | Contacting with Group 2A metal silicate catalyst; aluminum-free | THE DOW CHEMICAL COMPANY (US) | 1991-02-26 | — | — | US | disclosed |
| EP-0375355-A2 | Process for the catalytic reforming of alkylene amines to linearly-extended polyalkylene polyamines | THE DOW CHEMICAL COMPANY (US) | 1990-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220119583-A1 | SILYLAMINE COMPOUND AND LATENT CURING AGENT COMPRISING SAID SILYLAMINE COMPOUND | CDKN1A, SIRT2, H1-4 | ODC1 745/4885NFKB1 697/4885HTT 4234/4885 |
| US-12091491-B2 | Silylamine compound and latent curing agent comprising said silylamine compound | CDKN1A, SIRT2, H1-4 | ODC1 745/4885NFKB1 697/4885HTT 4234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.